FENS  

FENS Forum 2008 - Geneva

- For posters, morning sessions: 9:30-13:30; afternoon sessions 13:30- 17:30.
  Authors are expected to be in attendance at their posters at the time indicated.
- For other sessions, time indicates the beginning and end of the sessions.
- Click on the abstract number to view/print the abstract.
 

Close   Print    >> Symposia

Symposium S56 - Session 234 - Wednesday 16/07/2008, 09:45-11:15
Room Salève
Glycogen synthase kinase 3 (GSK3) in synaptic plasticity, memory and disease.

Chaired by: Jope R.S. (Birmingham, USA), Plattner F. (London, United Kingdom)

234.1. Symposium S56-1. Wed 16/07/2008, 09:45 - 11:15 (Presentation: 09:50) - Room Salève
Collingridge G. L.
MRC Centre, Bristol, United Kingdom
- GSK3 IN SYNAPTIC PLASTICITY.

234.2. Symposium S56-2. Wed 16/07/2008, 09:45 - 11:15 (Presentation: 10:10) - Room Salève
Lucas J. J. (1, 2)
(1) Centro Biol. Mol. "Severo Ochoa" (CBM"SO"). CSIC/UAM, Madrid, Spain; (2) CiberNed, Madrid, Spain
- MOUSE MODELS WITH MODIFIED GSK3 EXPRESSION TO STUDY ITS PHYSIOLOGICAL ROLE AND ITS IMPLICATION IN NEURODEGENERATIVE DISEASES.

234.3. Symposium S56-3. Wed 16/07/2008, 09:45 - 11:15 (Presentation: 10:30) - Room Salève
Klein P. S., O'Brien W. T. & Fagan R.
Univ. Penn. Sch. Med., Philadelphia, USA
- GSK3 AS A TARGET OF LITHIUM ACTION IN PSYCHIATRIC AND NEURODEGENERATIVE DISORDERS.

234.4. Symposium S56-4. Wed 16/07/2008, 09:45 - 11:15 (Presentation: 10:50) - Room Salève
Caron M. G. (1), Beaulieu J. M. (2), Salahpour A. (2), Masri B. (2) & Gainetdinov R. R. (2)
(1) Dept. Cell Bio, Med. and Neurobio, Duke Univ. Med. Ctr., Durham, USA; (2) Dept. Cell Bio, Duke Univ. Med. Ctr., Durham, USA
- THE AKT/GSK-3 SIGNALING PATHWAY MEDIATES THE ACTIONS OF DOPAMINE THROUGH A BETA-ARRESTIN 2-DEPENDENT MECHANISM THAT IS THE TARGET OF PSYCHOACTIVE AGENTS.


Top Copyright © 2008 - Federation of European Neuroscience Societies (FENS)